OKYO Pharma Ltd (OKYO)
About OKYO Pharma Ltd
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $85.0M
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $85.0M
- Shares outstanding
- 54.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 17, 2022
OKYO Pharma Ltd (OKYO) Stock Price
- Trading 53% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review OKYO Pharma Ltd.
Write a review
News about OKYO Pharma Ltd
News & sentiment via Polygon.io
OKYO Pharma Ltd: frequently asked questions
Is OKYO Pharma Ltd an American company?
OKYO Pharma Ltd is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is OKYO Pharma Ltd publicly traded?
Yes — OKYO Pharma Ltd is a publicly traded company. Its stock trades under the ticker symbol OKYO on the NASDAQ.
What does OKYO Pharma Ltd do?
OKYO Pharma Ltd is an American Pharmaceuticals company in the Health & Beauty sector.
